Bivalirudin (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Bivalirudin drug offered from Fresenius Kabi USA, LLC. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Bivalirudin |
| SUBSTANCE NAME: | BIVALIRUDIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-30 |
| END MARKETING DATE: | 0000-00-00 |
Bivalirudin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bivalirudin from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2017-10-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-562_50975be1-6d1f-497c-b989-1825a0fae1a7 |
| PRODUCT NDC: | 63323-562 |
| APPLICATION NUMBER: | ANDA090189 |
Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:
